James M S Wason

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method

Svetlana Cherlin, James M S Wason, J. Wason, 2020, Biostatistics.

Bayesian design and analysis of external pilot trials for complex interventions

Duncan T. Wilson, Duncan T Wilson, Amanda J Farrin, 2019, Statistics in medicine.

Cross-validated risk scores adaptive enrichment (CADEN) design

Svetlana Cherlin, James M S Wason, J. Wason, 2021, 2111.02299.

Admissible two‐stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis

Adrian P Mander, Simon G Thompson, Michael J Sweeting, 2012, Pharmaceutical statistics.

Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points.

Adrian P Mander, James M S Wason, J. Wason, 2011, European journal of cancer.

Planning multi-arm screening studies within the context of a drug development program

Nigel Stallard, Thomas Jaki, James M S Wason, 2013, Statistics in medicine.

A general framework for two-stage analysis of genome-wide association studies and its application to case-control studies.

Frank Dudbridge, James M S Wason, J. Wason, 2012, American journal of human genetics.